Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Current HIV/AIDS Reports
Erschienen in: Current HIV/AIDS Reports 3/2019

10.06.2019 | The Science of Prevention (JD Stekler and JM Baeten, Section Editors)

Confronting Rising STIs in the Era of PrEP and Treatment as Prevention

verfasst von: Meena S. Ramchandani, Matthew R. Golden

Erschienen in: Current HIV/AIDS Reports | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

This study aims to review the epidemiology of sexually transmitted infections (STIs) among men who have sex with men (MSM) and suggest control measures.

Recent Findings

Despite declines in new HIV diagnosis, bacterial STIs among MSM have dramatically risen since the late 1990s. This increase occurred concurrent with introduction of effective antiretroviral therapy, the advent of electronic mechanisms for meeting sex partners and population-level changes in sexual behavior, including decreased condom use. HIV pre-exposure prophylaxis (PrEP) is now further diminishing condom use, though its impact on STIs is uncertain. A plan to confront the MSM STI epidemic should include increased HIV/STI testing promoted through expanded public health clinical infrastructure, health care system reform to improve the care of gender and sexual minorities and promote low-barrier care, re-invigorated condom promotion, and scientific innovation.

Summary

There is an urgent need to implement new STI control measures while continuing to expand PrEP use.
Literatur
1.
2.
Purcell DW, Johnson CH, Lansky A, Prejean J, Stein R, Denning P, et al. Estimating the population size of men who have sex with men in the United States to obtain HIV and syphilis rates. Open AIDS J. 2012;6:98–107.
3.
Chan GA, Johnson KL, Mosca NG, Dobbs TE, Dombrowski JC, Bennett AB, et al. Emerging regional and racial disparities in the lifetime risk of human immunodeficiency virus infection among men who have sex with men: a comparative life table analysis in King County, WA and Mississippi. Sex Transm Dis. 2017;44:227–32.
4.
Sullivan PS, Rosenberg ES, Sanchez TH, Kelley CF, Luisi N, Cooper HL, et al. Explaining racial disparities in HIV incidence in black and white men who have sex with men in Atlanta, GA: a prospective observational cohort study. Ann Epidemiol. 2015;25:445–54.
5.
6.
7.
8.
Fauci AS, Redfield RR, Sigounas G, Weahkee MD, Giroir BP. Ending the HIV epidemic: a plan for the United States. JAMA. 2019;321:844.CrossRefPubMed
9.
10.
Abara WE, Hess KL, Neblett Fanfair R, Bernstein KT, Paz-Bailey G. Syphilis trends among men who have sex with men in the United States and Western Europe: a systematic review of trend studies published between 2004 and 2015. PLoS One. 2016;11:e0159309.CrossRefPubMedPubMedCentral
11.
Jasek E, Chow EP, Ong JJ, Bradshaw CS, Chen MY, Hocking JS, et al. Sexually transmitted infections in Melbourne, Australia from 1918 to 2016: nearly a century of data. Commun Dis Intell Q Rep. 2017;41:E212–22.
12.
•• Nguyen TQ, Kohn RP, Chew Ng R, Philip SS, Cohen SE. Historical and current trends in the epidemiology of early syphilis in San Francisco, 1955-2016. Sex Transm Dis. 2018. This is a well detailed review of trends of syphilis in San Francisco over a number of years based on data from San Francisco Department of Health;45:S55–62.CrossRefPubMed
13.
14.
Stenger MR, Pathela P, Anschuetz G, Bauer H, Simon J, Kohn R, et al. Increases in the rate of Neisseria gonorrhoeae among gay, bisexual and other men who have sex with men-findings from the sexually transmitted disease surveillance network 2010-2015. Sex Transm Dis. 2017;44:393–7.
15.
16.
17.
Mohan K, Hibbert M, Rooney G, Canvin M, Childs T, Jenkins C, et al. What is the overlap between HIV and shigellosis epidemics in England: further evidence of MSM transmission? Sex Transm Infect. 2018;94:67–71.
18.
Bowen A, Grass J, Bicknese A, Campbell D, Hurd J, Kirkcaldy RD. Elevated risk for antimicrobial drug-resistant Shigella infection among men who have sex with men, United States, 2011-2015. Emerg Infect Dis. 2016;22:1613–6.CrossRefPubMedPubMedCentral
19.
Hagan H, Jordan AE, Neurer J, Cleland CM. Incidence of sexually transmitted hepatitis C virus infection in HIV-positive men who have sex with men. AIDS. 2015;29:2335–45.CrossRefPubMedPubMedCentral
20.
Medland NA, Chow EP, Bradshaw CS, Read TH, Sasadeusz JJ, Fairley CK. Predictors and incidence of sexually transmitted hepatitis C virus infection in HIV positive men who have sex with men. BMC Infect Dis. 2017;17:185.CrossRefPubMedPubMedCentral
21.
Johnson AM, Gill ON. Evidence for recent changes in sexual behaviour in homosexual men in England and Wales. Philos Trans R Soc Lond Ser B Biol Sci. 1989;325:153–61.CrossRef
22.
Dawson JM, Fitzpatrick RM, Reeves G, Boulton M, McLean J, Hart GJ, et al. Awareness of sexual partners’ HIV status as an influence upon high-risk sexual behaviour among gay men. AIDS. 1994;8:837–41.
23.
Kippax S, Noble J, Prestage G, Crawford JM, Campbell D, Baxter D, et al. Sexual negotiation in the AIDS era: negotiated safety revisited. AIDS. 1997;11:191–7.
24.
Elford J, Bolding G, Davis M, Sherr L, Hart G. Trends in sexual behaviour among London homosexual men 1998-2003: implications for HIV prevention and sexual health promotion. Sex Transm Infect. 2004;80:451–4.CrossRefPubMedPubMedCentral
25.
Golden MR, Stekler J, Hughes JP, Wood RW. HIV serosorting in men who have sex with men: is it safe? J Acquir Immune Defic Syndr. 2008;49:212–8.CrossRefPubMed
26.
Khosropour CM, Dombrowski JC, Swanson F, Kerani RP, Katz DA, Barbee LA, et al. Trends in serosorting and the association with HIV/STI risk over time among men who have sex with men. J Acquir Immune Defic Syndr. 2016;72:189–97.
27.
28.
•• Golden M. Syphilis in the Era of treatment as prevention and pre-exposure prophylaxis. Conference on retroviruses and opportunistic infections. Seattle, WA. 2017. An oral abstract covering the challenges and opportunities in STI control to mitigate the morbidity of infection and spread.
29.
Brennan DJ, Welles SL, Miner MH, Ross MW, Rosser BR, Positive Connections T. HIV treatment optimism and unsafe anal intercourse among HIV-positive men who have sex with men: findings from the positive connections study. AIDS Educ Prev. 2010;22:126–37.CrossRefPubMedPubMedCentral
30.
• Sullivan PS, Drake AJ, Sanchez TH. Prevalence of treatment optimism-related risk behavior and associated factors among men who have sex with men in 11 states, 2000–2001. AIDS Behav. 2007;11:123–9. A study that evaluates the association of high risk sex behaviors with HIV treatment optimism in MSM in the early 2000s.CrossRefPubMed
31.
Stolte IG, Dukers NH, Geskus RB, Coutinho RA, de Wit JB. Homosexual men change to risky sex when perceiving less threat of HIV/AIDS since availability of highly active antiretroviral therapy: a longitudinal study. AIDS. 2004;18:303–9.CrossRefPubMed
32.
Dukers NH, Goudsmit J, de Wit JB, Prins M, Weverling GJ, Coutinho RA. Sexual risk behaviour relates to the virological and immunological improvements during highly active antiretroviral therapy in HIV-1 infection. AIDS. 2001;15:369–78.CrossRefPubMed
33.
Kelly JA, Hoffman RG, Rompa D, Gray M. Protease inhibitor combination therapies and perceptions of gay men regarding AIDS severity and the need to maintain safer sex. AIDS. 1998;12:F91–5.CrossRefPubMed
34.
Dilley JW, Woods WJ, McFarland W. Are advances in treatment changing views about high-risk sex? N Engl J Med. 1997;337:501–2.CrossRefPubMed
35.
Ostrow DE, Fox KJ, Chmiel JS, Silvestre A, Visscher BR, Vanable PA, et al. Attitudes towards highly active antiretroviral therapy are associated with sexual risk taking among HIV-infected and uninfected homosexual men. AIDS. 2002;16:775–80.
36.
Elford J, Bolding G, Sherr L. High-risk sexual behaviour increases among London gay men between 1998 and 2001: what is the role of HIV optimism? AIDS. 2002;16:1537–44.CrossRefPubMed
37.
Williamson LM, Hart GJ. HIV optimism does not explain increases in high-risk sexual behaviour among gay men in Scotland. AIDS. 2004;18:834–5.CrossRefPubMed
38.
International Collaboration on HIVO. HIV treatments optimism among gay men: an international perspective. J Acquir Immune Defic Syndr. 2003;32:545–50.CrossRef
39.
Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Antiretroviral therapy for the prevention of HIV-1 transmission. N Engl J Med. 2016;375:830–9.
40.
• Roth EA, Cui Z, Rich A, Lachowsky N, Sereda P, Card KG, et al. Seroadaptive Strategies of Vancouver Gay and Bisexual Men in a Treatment as Prevention Environment. J Homosex. 2018;65:524–39. This article discusses seroadapative strategies in MSM with relation to ART and treatment optimism.
41.
Holt M, Lea T, Mao L, Zablotska I, Prestage G, de Wit J. Brief report: HIV prevention by Australian gay and bisexual men with casual partners: the emergence of undetectable viral load as one of a range of risk reduction strategies. J Acquir Immune Defic Syndr. 2015;70:545–8.CrossRefPubMed
42.
Van Den Boom W, Stolte IG, Witlox R, Sandfort T, Prins M, Davidovich U. Undetectable viral load and the decision to engage in unprotected anal intercourse among HIV-positive MSM. AIDS Behav. 2013;17:2136–42.CrossRefPubMedCentral
43.
Kim AA, Kent C, McFarland W, Klausner JD. Cruising on the internet highway. J Acquir Immune Defic Syndr. 2001;28:89–93.CrossRefPubMed
44.
Bolding G, Davis M, Hart G, Sherr L, Elford J. Where young MSM meet their first sexual partner: the role of the internet. AIDS Behav. 2007;11:522–6.CrossRefPubMed
45.
Klausner JD, Wolf W, Fischer-Ponce L, Zolt I, Katz MH. Tracing a syphilis outbreak through cyberspace. JAMA. 2000;284:447–9.CrossRefPubMed
46.
DeVost MA, Beymer MR, Weiss RE, Shover CL, Bolan RK. App-based sexual partner seeking and sexually transmitted infection outcomes: a cross-sectional study of HIV-negative men who have sex with men attending a sexually transmitted infection clinic in Los Angeles, California. Sex Transm Dis. 2018;45:394–9.CrossRefPubMedPubMedCentral
47.
Hull P, Mao L, Prestage G, Zablotska I, de Wit J, Holt M. The use of mobile phone apps by Australian gay and bisexual men to meet sex partners: an analysis of sex-seeking repertoires and risks for HIV and STIs using behavioural surveillance data. Sex Transm Infect. 2016;92:502–7.CrossRefPubMed
48.
Lehmiller JJ, Ioerger M. Social networking smartphone applications and sexual health outcomes among men who have sex with men. PLoS One. 2014;9:e86603.CrossRefPubMedPubMedCentral
49.
Phillips G 2nd, Magnus M, Kuo I, Rawls A, Peterson J, Jia Y, et al. Use of geosocial networking (GSN) mobile phone applications to find men for sex by men who have sex with men (MSM) in Washington, DC. AIDS Behav. 2014;18:1630–7.CrossRefPubMed
50.
Zou H, Fan S. Characteristics of men who have sex with men who use smartphone geosocial networking applications and implications for HIV interventions: a systematic review and meta-analysis. Arch Sex Behav. 2017;46:885–94.CrossRefPubMed
51.
Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363:2587–99.
52.
Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367:399–410.
53.
Marrazzo JM, del Rio C, Holtgrave DR, Cohen MS, Kalichman SC, Mayer KH, et al. HIV prevention in clinical care settings: 2014 recommendations of the international antiviral society-USA panel. JAMA. 2014;312:390–409.
54.
McCormack S, Dunn DT, Desai M, Dolling DI, Gafos M, Gilson R, et al. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet. 2016;387:53–60.
55.
Liu AY, Vittinghoff E, Chillag K, Mayer K, Thompson M, Grohskopf L, et al. Sexual risk behavior among HIV-uninfected men who have sex with men participating in a tenofovir preexposure prophylaxis randomized trial in the United States. J Acquir Immune Defic Syndr. 2013;64:87–94.
56.
Hosek SG, Siberry G, Bell M, Lally M, Kapogiannis B, Green K, et al. The acceptability and feasibility of an HIV preexposure prophylaxis (PrEP) trial with young men who have sex with men. J Acquir Immune Defic Syndr. 2013;62:447–56.
57.
Fonner VA, Dalglish SL, Kennedy CE, Baggaley R, O’Reilly KR, Koechlin FM, et al. Effectiveness and safety of oral HIV preexposure prophylaxis for all populations. AIDS. 2016;30:1973–83.CrossRefPubMedPubMedCentral
58.
Grant RM, Anderson PL, McMahan V, Liu A, Amico KR, Mehrotra M, et al. Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study. Lancet Infect Dis. 2014;14:820–9.
59.
Liu AY, Cohen SE, Vittinghoff E, Anderson PL, Doblecki-Lewis S, Bacon O, et al. Preexposure prophylaxis for HIV infection integrated with municipal- and community-based sexual health services. JAMA Intern Med. 2016;176:75–84.
60.
Golub SA, Kowalczyk W, Weinberger CL, Parsons JT. Preexposure prophylaxis and predicted condom use among high-risk men who have sex with men. J Acquir Immune Defic Syndr. 2010;54:548–55.CrossRefPubMedPubMedCentral
61.
Brooks RA, Landovitz RJ, Kaplan RL, Lieber E, Lee SJ, Barkley TW. Sexual risk behaviors and acceptability of HIV pre-exposure prophylaxis among HIV-negative gay and bisexual men in serodiscordant relationships: a mixed methods study. AIDS Patient Care STDs. 2012;26:87–94.CrossRefPubMedPubMedCentral
62.
Grov C, Whitfield TH, Rendina HJ, Ventuneac A, Parsons JT. Willingness to take PrEP and potential for risk compensation among highly sexually active gay and bisexual men. AIDS Behav. 2015;19:2234–44.CrossRefPubMedPubMedCentral
63.
Hoff CC, Chakravarty D, Bircher AE, Campbell CK, Grisham K, Neilands TB, et al. Attitudes towards PrEP and anticipated condom use among concordant HIV-negative and HIV-discordant male couples. AIDS Patient Care STDs. 2015;29:408–17.
64.
Molina JM, Charreau I, Spire B, Cotte L, Chas J, Capitant C, et al. Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study. Lancet HIV. 2017;4:e402–10.
65.
Lal L, Audsley J, Murphy DA, Fairley CK, Stoove M, Roth N, et al. Medication adherence, condom use and sexually transmitted infections in Australian preexposure prophylaxis users. AIDS. 2017;31:1709–14.
66.
Oldenburg CE, Nunn AS, Montgomery M, Almonte A, Mena L, Patel RR, et al. Behavioral changes following uptake of HIV pre-exposure prophylaxis among men who have sex with men in a clinical setting. AIDS Behav. 2018;22:1075–9.
67.
Zablotska IVS, Bloch M, Carr A, Foster R, Grulich A, Guy R, et al. No HIV infections despite high-risk behaviour and STI incidence among gay/bisexual men taking daily pre-exposure prophylaxis (PrEP): the PRELUDE demonstration project. Paris, France: International AIDS society conference on HIV science; 2017.
68.
• Traeger MW, Schroeder SE, Wright EJ, Hellard ME, Cornelisse VJ, Doyle JS, et al. Effects of pre-exposure prophylaxis for the prevention of HIV infection on sexual risk behavior in men who have sex with men: a systematic review and meta-analysis. Clin Infect Dis. 2018. A review evaluating risk compensation in PrEP users, highlighting the increase in condomless sex among PrEP users.
69.
Milam J, Jain S, Dube MP, Daar ES, Sun X, Corado K, et al. Sexual risk compensation in a pre-exposure prophylaxis demonstration study among individuals at risk of HIV. J Acquir Immune Defic Syndr. 2019;80:e9–e13.CrossRefPubMed
70.
•• Montano MA, Dombrowski JC, Dasgupta S, Golden MR, Duerr A, Manhart LE, et al. Changes in sexual behavior and STI diagnoses among MSM initiating PrEP in a clinic setting. AIDS Behav. 2019;23:548–55. A study measuring changes in sexual behaviors and incidence of STIs in MSM in the periods prior to and during PrEP use. This is one of the few studies that accounts for the effect of ascertainment bias resulting from increased testing frequency.
71.
Volk JE, Marcus JL, Phengrasamy T, Blechinger D, Nguyen DP, Follansbee S, et al. No new HIV infections with increasing use of HIV preexposure prophylaxis in a clinical practice setting. Clin Infect Dis. 2015;61:1601–3.
72.
Hosek SG, Rudy B, Landovitz R, Kapogiannis B, Siberry G, Rutledge B, et al. An HIV preexposure prophylaxis demonstration project and safety study for young MSM. J Acquir Immune Defic Syndr. 2017;74:21–9.
73.
Hightow-Weidman LB, Magnus M, Beauchamp G, Hurt CB, Shoptaw S, Emel L, et al. Incidence and correlates of STIs among black men who have sex with men participating in the HPTN 073 PrEP study. Clin Infect Dis. 2019.
74.
Beymer MR, DeVost MA, Weiss RE, Dierst-Davies R, Shover CL, Landovitz RJ, et al. Does HIV pre-exposure prophylaxis use lead to a higher incidence of sexually transmitted infections? A case-crossover study of men who have sex with men in Los Angeles, California. Sex Transm Infect. 2018;94:457–62.CrossRefPubMedPubMedCentral
75.
Marcus JL, Hurley LB, Hare CB, Nguyen DP, Phengrasamy T, Silverberg MJ, et al. Preexposure prophylaxis for HIV prevention in a large integrated Health care system: adherence, renal safety, and discontinuation. J Acquir Immune Defic Syndr. 2016;73:540–6.
76.
• Nguyen VK, Greenwald ZR, Trottier H, Cadieux M, Goyette A, Beauchemin M, et al. Incidence of sexually transmitted infections before and after preexposure prophylaxis for HIV. AIDS. 2018;32:523–30. A study that evaluates the incidence of STIs over the 12 months before and after PrEP initiation in MSM.
77.
Jenness SM, Weiss KM, Goodreau SM, Gift T, Chesson H, Hoover KW, et al. Incidence of gonorrhea and chlamydia following human immunodeficiency virus Preexposure prophylaxis among men who have sex with men: a modeling study. Clin Infect Dis. 2017;65:712–8.
78.
Holt M, Hull P, Lea T, Guy R, Bourne C, Prestage G, et al. Comprehensive testing for, and diagnosis of, sexually transmissible infections among Australian gay and bisexual men: findings from repeated, cross-sectional behavioural surveillance, 2003-2012. Sex Transm Infect. 2014;90:208–15.
79.
Dombrowski JC, Pedersen R, Marra CM, Kerani RP, Golden MR. Prevalence estimates of complicated syphilis. Sex Transm Dis. 2015;42:702–4.CrossRefPubMed
80.
Oliver SE, Cope AB, Rinsky JL, Williams C, Liu G, Hawks S, et al. Increases in ocular syphilis-North Carolina, 2014-2015. Clin Infect Dis. 2017;65:1676–82.
81.
Woolston S, Cohen SE, Fanfair RN, Lewis SC, Marra CM, Golden MR. A cluster of ocular syphilis cases - Seattle, Washington, and San Francisco, California, 2014-2015. MMWR Morb Mortal Wkly Rep. 2015;64:1150–1.CrossRefPubMedPubMedCentral
82.
Ramchandani M, Litvack J, Maxwell C, Tantalo L, Sahi S, Dunaway S, Marra C. Hearing loss in unselected individuals with syphilis. Conference on retroviruses and opportunistic infections. Seattle, Washington 2019.
83.
Workowski KA, Bolan GA, Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep. 2015;2015(64):1–137.
84.
Owusu-Edusei K Jr, Roby TM, Chesson HW, Gift TL. Productivity costs of nonviral sexually transmissible infections among patients who miss work to seek medical care: evidence from claims data. Sex Health. 2013;10:434–7.CrossRefPubMed
85.
Kelley CF, Vaughan AS, Luisi N, Sanchez TH, Salazar LF, Frew PM, et al. The effect of high rates of bacterial sexually transmitted infections on HIV incidence in a cohort of black and white men who have sex with men in Atlanta, Georgia. AIDS Res Hum Retrovir. 2015;31:587–92.
86.
Barbee LA, Khosropour CM, Dombrowksi JC, Golden MR. New human immunodeficiency virus diagnosis independently associated with rectal gonorrhea and chlamydia in men who have sex with men. Sex Transm Dis. 2017;44:385–9.CrossRefPubMedPubMedCentral
87.
Holmes KK, Stamm WE. Lower genital tract infection syndromes in women. In: Holmes KK, Sparling PF, Mardh P, et al., editors. Sexually transmitted diseases. Third ed. New York: McGraw-Hill; 1999. p. 761–81.
88.
Ison CA, Hussey J, Sankar KN, Evans J, Alexander S. Gonorrhoea treatment failures to cefixime and azithromycin in England. Euro Surveill. 2010;2011:16.
89.
Gose SO, Soge OO, Beebe JL, Nguyen D, Stoltey JE, Bauer HM. Failure of azithromycin 2.0 g in the treatment of gonococcal urethritis caused by high-level resistance in California. Sex Transm Dis. 2015;42:279–80.CrossRefPubMedPubMedCentral
90.
Papp JR, Abrams AJ, Nash E, Katz AR, Kirkcaldy RD, O'Connor NP, et al. Azithromycin resistance and decreased ceftriaxone susceptibility in Neisseria gonorrhoeae, Hawaii, USA. Emerg Infect Dis. 2017;23:830–2.CrossRefPubMedPubMedCentral
91.
Day MJ, Spiteri G, Jacobsson S, Woodford N, Amato-Gauci AJ, Cole MJ, et al. Stably high azithromycin resistance and decreasing ceftriaxone susceptibility in Neisseria gonorrhoeae in 25 European countries, 2016. BMC Infect Dis. 2018;18:609.CrossRefPubMedPubMedCentral
92.
93.
•• Golden MR, Dombrowski JC. Syphilis control in the post-elimination era: implications of a new syphilis control initiative for STD/HIV programs. Sex Transm Dis. 2017. An article that highlights the need for control of syphilis as case rates continue to rise. This article presents intervention strategies which are needed at local and national levels.
94.
•• Clutterbuck D, Asboe D, Barber T, Emerson C, Field N, Gibson S, et al. United Kingdom national guideline on the sexual health care of men who have sex with men. Int J STD AIDS. 2016;2018:956462417746897. A guideline to consider in the sexual health care of MSM to serve as a starting point for local guidelines.
95.
96.
Dombrowski JC, Golden MR, Barbee LA, Khosropour CM. Patient disengagement from an HIV pre-exposure prophylaxis program in a sexually transmitted disease clinic. Sex Transm Dis. 2018:1.
97.
98.
Nwokolo N, Whitlock G, McOwan A. Not just PrEP: other reasons for London's HIV decline. Lancet HIV. 2017;4:e153.CrossRefPubMed
99.
Whitlock GG, Gibbons DC, Longford N, Harvey MJ, McOwan A, Adams EJ. Rapid testing and treatment for sexually transmitted infections improve patient care and yield public health benefits. Int J STD AIDS. 2018;29:474–82.CrossRefPubMed
100.
Freeman AH, Bernstein KT, Kohn RP, Philip S, Rauch LM, Klausner JD. Evaluation of self-collected versus clinician-collected swabs for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae pharyngeal infection among men who have sex with men. Sex Transm Dis. 2011;38:1036–9.CrossRefPubMed
101.
Schachter J, Chernesky MA, Willis DE, Fine PM, Martin DH, Fuller D, et al. Vaginal swabs are the specimens of choice when screening for Chlamydia trachomatis and Neisseria gonorrhoeae: results from a multicenter evaluation of the APTIMA assays for both infections. Sex Transm Dis. 2005;32:725–8.
102.
103.
104.
Tung EL, Thomas A, Eichner A, Shalit P. Implementation of a community pharmacy-based pre-exposure prophylaxis service: a novel model for pre-exposure prophylaxis care. Sex Health. 2018;15:556–61.CrossRefPubMed
105.
Preeti P JK, Blank S, Mikati T, Hedberg T, Golub SA, et al. The PrEP cascade at NYC sexual health clinics: navigation is the key to uptake. Conference on retroviruses and opportunistic infections. Boston, MA. 2018.
106.
Golub S, Pena S, Fikslin RA, Goldberg M, A Radix, Partners, not condom use, drive STI rates among PrEP users in community health center. Conference on retroviruses and opportunistic infections. Boston, MA. 2018.
107.
Suzan-Monti M, Cotte L, Fressard L, Cua E, Capitant C, Meyer L, et al. Factors associated with partner notification of STIs in men who have sex with men on PrEP in France: a cross-sectional substudy of the ANRS-IPERGAY trial. Sex Transm Infect. 2018;94:490–3.
108.
Katz DA, Dombrowski JC, Barry M, Spellman D, Bell TR, Golden MR. STD partner services to monitor and promote HIV pre-exposure prophylaxis use among men who have sex with men. J Acquir Immune Defic Syndr. 2019;80:533–41.CrossRefPubMed
109.
Barbee LA, Tat S, Dhanireddy S, Marrazzo JM. Implementation and operational research: effectiveness and patient acceptability of a sexually transmitted infection self-testing program in an HIV care setting. J Acquir Immune Defic Syndr. 2016;72:e26–31.CrossRefPubMedPubMedCentral
110.
Bissessor M, Fairley CK, Leslie D, Howley K, Chen MY. Frequent screening for syphilis as part of HIV monitoring increases the detection of early asymptomatic syphilis among HIV-positive homosexual men. J Acquir Immune Defic Syndr. 2010;55:211–6.CrossRefPubMed
111.
Chow EPF, Callander D, Fairley CK, Zhang L, Donovan B, Guy R, et al. Increased syphilis testing of men who have sex with men: greater detection of asymptomatic early syphilis and relative reduction in secondary syphilis. Clin Infect Dis. 2017;65:389–95.
112.
Desai M, Woodhall SC, Nardone A, Burns F, Mercey D, Gilson R. Active recall to increase HIV and STI testing: a systematic review. Sex Transm Infect. 2015;91:314–23.CrossRefPubMed
113.
Smith KS, Hocking JS, Chen MY, Fairley CK, McNulty AM, Read P, et al. Dual intervention to increase chlamydia retesting: a randomized controlled trial in three populations. Am J Prev Med. 2015;49:1–11.CrossRefPubMed
114.
115.
116.
117.
118.
Molina JM, Charreau I, Chidiac C, Pialoux G, Cua E, Delaugerre C, et al. Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial. Lancet Infect Dis. 2018;18:308–17.
119.
Bolan RK, Beymer MR, Weiss RE, Flynn RP, Leibowitz AA, Klausner JD. Doxycycline prophylaxis to reduce incident syphilis among HIV-infected men who have sex with men who continue to engage in high-risk sex: a randomized, controlled pilot study. Sex Transm Dis. 2015;42:98–103.CrossRefPubMedPubMedCentral
120.
Gliddon HD, Peeling RW, Kamb ML, Toskin I, Wi TE, Taylor MM. A systematic review and meta-analysis of studies evaluating the performance and operational characteristics of dual point-of-care tests for HIV and syphilis. Sex Transm Infect. 2017;93:S3–S15.CrossRefPubMed
121.
Gaydos C, Hardick J. Point of care diagnostics for sexually transmitted infections: perspectives and advances. Expert Rev Anti-Infect Ther. 2014;12:657–72.CrossRefPubMedPubMedCentral
122.
Petousis-Harris H, Paynter J, Morgan J, Saxton P, McArdle B, Goodyear-Smith F, et al. Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study. Lancet. 2017;390:1603–10.
Metadaten
Titel
Confronting Rising STIs in the Era of PrEP and Treatment as Prevention
verfasst von
Meena S. Ramchandani
Matthew R. Golden
Publikationsdatum
10.06.2019
Verlag
Springer US
Erschienen in
Current HIV/AIDS Reports / Ausgabe 3/2019
Print ISSN: 1548-3568
Elektronische ISSN: 1548-3576
DOI
https://doi.org/10.1007/s11904-019-00446-5

Weitere Artikel der Ausgabe 3/2019

Current HIV/AIDS Reports 3/2019 Zur Ausgabe

Correction

Correction to: Scaling-up PrEP Delivery in Sub-Saharan Africa: What Can We Learn from the Scale-up of ART?

HIV Pathogenesis and Treatment (AL Landay and NS Utay, Section Editors)

Pathogenic Role of Type I Interferons in HIV-Induced Immune Impairments in Humanized Mice

HIV Pathogenesis and Treatment (AL Landay and NS Utay, Section Editors)

Innate Lymphoid Cells: Their Contributions to Gastrointestinal Tissue Homeostasis and HIV/SIV Disease Pathology

HIV Pathogenesis and Treatment (AL Landay and NS Utay, Section Editors)

Lipidome Abnormalities and Cardiovascular Disease Risk in HIV Infection

Central Nervous System and Cognition (S Spudich, Section Editor)

Neurocognitive Phenotyping of HIV in the Era of Antiretroviral Therapy

HIV Pathogenesis and Treatment (AL Landay and NS Utay, Section Editors)

HIV and the Gut Microbiota: Composition, Consequences, and Avenues for Amelioration

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise